Biotechnology
Regor to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
CAMBRIDGE, Mass., June 5, 2024 /PRNewswire/ -- Regor Therapeutics Group, a clinical-stage global biopharmaceutical company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Thursday, June 12. Dr.Xiayang Qiu, Founder and CEO, will rep...
FDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for mCRPC
HEFEI, China, June 5, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has recently approved a Phase II/III clinical trial of KPG-121 in combination with Abiraterone for a first-line treatment of metastatic castration resistant prost...
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
* I-Mab enters clinical collaboration with Bristol Myers Squibb to evaluate Claudin 18.2 x 4-1BB bispecific antibody givastomig in combination with nivolumab and chemotherapy for the treatment of gastric and esophageal cancer. * Collaboration builds on promising safety and efficacy data from t...
Perfect Diary's Parent Company Yatsen Group Officially Unveils Global Innovation and R&D Center
Initial Investment of Over RMB 80 Million Marks a New Era of Innovation for the Company SHANGHAI, June 5, 2024 /PRNewswire/ -- On May 28, Yatsen Group, the parent company of Perfect Diary, held the grand opening of the new Global Innovation R&D Center ("the Center") inShanghai. As the first¹ glo...
Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series
XI'AN, China, June 5, 2024 /PRNewswire/ -- In honor of World Environment Day on
5 June,Tianlong
GC Genome Highlights Promising New Approach for Non-invasive Colorectal Cancer Detection at ASCO 2024
YONGIN, South Korea, June 5, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, presented new data from its AI-based liquid biopsy platform for non-invasive colorectal cancer (CRC) detection at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Conducted...
Live from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3%
SUZHOU, China and ROCKVILLE, Md., June 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated clinical data of olvere...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data Showing Promising Efficacy and Safety of Lisaftoclax in Patients with WM
SUZHOU, China, and ROCKVILLE, Md., June 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated results from a global,...
Xinhua Silk Road: Enterprise in E. China's Shandong Weihai dedicated to American ginseng products dev't
BEIJING, June 5, 2024 /PRNewswire/ -- In the workshops of Shandong Yiyang Biotechnology Co., Ltd. (Yiyang Biotechnology) in Weihai City, eastChina's Shandong Province, four new intelligent production lines recently were busy producing various types of American ginseng products, which were later s...
Zymo Research Unveils PureRec DSN: The Most Selective Duplex-Specific Nuclease
IRVINE, Calif., June 4, 2024 /PRNewswire/ -- Zymo Research, a leader in biotechnological advancement has launched a new nuclease calledPureRec Duplex-Specific Nuclease (DSN) that selectively digests double stranded DNA (dsDNA). This new PureRec DSN promises unparalleled specificity in targeting ...
FDA Clearance For Gastrointestinal Parasite Detection Kit
MELBOURNE, Australia, June 4, 2024 /PRNewswire/ -- Genetic Signatures Limited [ASX:GSS]("GSS" or the "Company"), a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Company'sEasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 aut...
Angel Yeast Partners with BakeMark Launching Multiple Product Lines at Bakery China 2024
SHANGHAI, June 4, 2024 /PRNewswire/ -- Angel Yeast
MicroAlgo Inc. (NASDAQ: MLGO) Announced to Jointly Establish a Micro-Consciousness Quantum Research Center With WIMI (NASDAQ: WIMI)
BEIJING, June 4, 2024 /PRNewswire/ -- MicroAlgo Inc. (NASDAQ: MLGO) (the "Company" or "MicroAlgo"), today announced that MicroAlgo and WiMi will jointly establish a micro-consciousness quantum research center. It will integrate physics, mathematics, medicine, genetics, computer science, biology, ...
AmpleLogic Launches Advanced aPaaS for Life Sciences with 14 Ready-to-Use Applications
HYDERABAD, India, June 4, 2024 /PRNewswire/ -- AmpleLogic, a leading provider
of GAMP solutions, announces the launch of its revolutionaryApplication
Platform as a Service (aPaaS)
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings
YONGIN, South Korea, June 4, 2024 /PRNewswire/ -- GC Biopharma announced that it will attend 2024 Spring Symposium of the Korean American Society in Biotech and Pharmaceuticals (KASBP) onJune 7-8th at Waltham, Massachusetts as a sponsor to share keynote presentation, present Korean Scientist Awar...
Fapon Biopharma Announces a Safer Immunotherapy for Cancers
SAN DIEGO, June 3, 2024 /PRNewswire/ -- At Bio International Convention 2024, which is taking place here inSan Diego during June 3-6, Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, has announced an immunocytokine with modified IL-10M fused to anti-PD-1 ant...
RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88
YANTAI, China, June 4, 2024 /PRNewswire/ -- RemeGen Co., Ltd.
Built by Nature Prize Awards €500,000 to Biobased Construction Innovators
AMSTERDAM, June 4, 2024 /PRNewswire/ -- Built by Nature is pleased to announce the winners of its inaugural global Prize to stimulate uptake of innovative biobased construction materials, with a €250,000 first prize awarded toSingapore-based company Widuz for its bamboo product solutions. Widu...
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx
ADELAIDE, South Australia, June 3, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced the exclusive rights to utilize CelluTx's Recombination Based Plasmid System (RBPS) technology with BioCina's CDMO clients....
Datasea Agreement already provided $2.8 million Information Service for its Highly Specialized 5G-AI Communications Platform
Agreement to Have Powerful Revenue Impact and is Expected to Lead to More Lucrative Contracts BEIJING, June 3, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada company engaged in innovative business segments in high-tech intelligent acoustics and 5G-Artifici...
Week's Top Stories
Most Reposted
ASTON MARTIN ARAMCO FORMULA ONE® TEAM ANNOUNCE PEPPERSTONE AS OFFICAL TRADING PARTNER
[Picked up by 308 media titles]
2025-01-07 09:00RuggON Unveils VORTEX Vehicle Mount Computer with AI-Enhanced, SATCOM-Ready
[Picked up by 306 media titles]
2025-01-06 21:00Brewing Connections and Spotlighting Café Culture: MIFB 2025 Hosts MNCC in Collaboration with MSCA
[Picked up by 305 media titles]
2025-01-06 14:00iWOW Unveils Age-Tech Innovations at CES 2025, Expanding Portfolio of IoT Solutions for Ageing-In-Place
[Picked up by 294 media titles]
2025-01-07 21:18CELEBRATE THE LUNAR NEW YEAR 2025 AT HOIANA RESORT & GOLF, WORLD'S LEADING FULLY INTEGRATED RESORT
[Picked up by 290 media titles]
2025-01-06 19:25